Received: July 15, 2015 | Accepted: August 17, 2015 | Web Released: September 3, 2015
CL-150663
Green and Reusable Nanocatalyst for the Synthesis of 1,5-benzodiazepines
and Its Derivatives under Solvent-free Conditions
1
2
1
Kandregula Veera Venkata Satyanarayana, Matangi Ravi Chandra, Parimi Atchuta Ramaiah,
1
3
3
Yellajyosula Lakshmi Narasimha Murthy, Yoon Soon Gil, and Sri Venkata Narayana Pammi*
1
Department of Organic Chemistry Foods, Drugs and Water, College of Science and Technology, Andhra University,
Visakhapatnam 530003, India
2
Advanced Analytical Laboratory, DST-PURSE Programme, Andhra University, Visakhapatnam 530003, India
3
Department of Materials Science and Engineering, Chungnam National University, Daeduk Science Town, 305-764, Daejeon, Korea
(
E-mail: venkat@cnu.ac.kr)
Novel, reusable, and efficient (Cd, Zn) S nanocatalysts were
prepared by simple and economical chemical bath deposition
using a greener approach. The as-synthesized catalysts were
characterized by XRD, SEM, TEM, and FT-IR spectroscopy. The
catalytic activity of as-prepared nanocatalysts were examined for
the synthesis of 1,5-benzodiazepines and its derivatives under
solvent-free conditions without using any toxic materials. It has
been observed that CdS nanocatalyst shows superior catalytic
activity and is recyclable and reusable for ten runs without any
significant loss.
Scheme 1.
Benzodiazepines and their derivatives have received signifi-
cant attention due to their remarkable central nervous system
depressant activity and are now known to be one of the most
1
widely prescribed classes of psychotropics. They are broadly
used as antibiotics, and in various diseases such as cancer, viral
infection (HIV), and cardiovascular disorders and also useful in
the treatment of anxiety, insomnia, agitation, seizures, muscle
spasms, alcohol withdrawal and as a premedication for medical
2
,3
or dental procedures. The 1,5-benzodiazepine core is found
in compounds active against a variety of target types such as
peptide hormones, interleukin converting enzymes, and potassium
blockers. Furthermore, benzodiazepines also act as valuable
intermediates in the synthesis of fused ring compounds such
as triazolo-, oxadiazolo-, oxazino-, and furanobenzodiazepines.4
Figure 1. XRD patterns for ZnS and CdS nanoparticles.
ZnS and CdS nanoparticles were synthesized by simple chem-
ical bath deposition of Zn(CH3COO)2 (zinc acetate)/cadmium
acetate dihydrate (Cd(OAc)2)¢2H2O, trisodium citrate, NaOH and
thiourea solution and ethylene glycol containing PVP near room
temperature (ca. 35 °C). The product was separated from the
reaction mixture by centrifugation, washed several times with
ethanol and finally treated with 0.1 M HNO3. The detailed
experimental method is given in Supporting Information (SI).
The morphological, structural, chemical, and optical properties
of ZnS and CdS nanoparticles were analyzed with SEM, XRD,
EDAX, TEM, and FTIR techniques.
The XRD pattern (Figure 1) of ZnS nanoparticles exhibits
diffraction peaks which are significantly broadened because of
very small crystalline size. The ZnS nanoparticles exhibit
hexagonal structure (JCPDS No. 80-0007) with preferred orienta-
tion (002) along with (110), and (112) directions. The crystalline
size of ZnS nanoparticles and CdS nanoparticles was calculated
using the Scherrer formula and was found to be about 5 and 8 nm
respectively, indicating their nanocrystalline nature. On the other
hand, XRD pattern of CdS nanoparticles exhibits cubic phase with
preferred orientation (111) along with (220), (311) directions. No
metal or other phases were detected by XRD for ZnS and CdS
nanoparticles.
1
,5-Benzodiazepines are generally synthesized by acid-catalyzed
condensation of o-phenylenediamines with ketones. From the
reported literature, the synthesis of benzodiazepines includes usage
of various metal salts, CAN, heteropolyacids, ionic liquids, etc.5
However, most of these processes have certain limitations, such as
prolonged reaction time, use of strong acid or organic solvents,
generation of by-products, anhydrous conditions, poor yields,
and tedious work-up procedures. Therefore, improvements in this
synthesis have been sought continuously. In recent years, there
has been an upsurge of interest on the usage of heterogeneous
nanocatalyst because of their quantum size effect that leads to
increase in relative number of surface atoms and thus improvement
8
9
in catalytic activity. The usage of ZnS and CdS semiconductor
nanoparticles in biomedical applications has been studied.10
However, there are very few reports on the synthesis of 1,5-
benzodiazepines and their derivatives using nanocatalyst.11
In this article, we report the synthesis and characterization of
ZnS and CdS nanoparticles and examined the feasibility of catalytic
activity in the synthesis of 1,5-benzodiazepines and their deriva-
tives using the process of condensation of σ-phenylenediamine
with various ketones under solvent-free conditions (Scheme 1).
© 2015 The Chemical Society of Japan | 1589